H-1B sponsorship profile: Dicerna Pharmaceuticals, Inc. Across U.S. Department of Labor LCA disclosures, Dicerna Pharmaceuticals, Inc filed 25 Labor Condition Applications covering 25 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (25 certified of 25 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Dicerna Pharmaceuticals, Inc’s H-1B petitions range from $73,500 at the low end to $179,587 at the high end, with a petition-weighted average of $120,363. That range reflects the mix of occupations the company sponsors, led by Research Associate, RNAi Discovery (3 petitions at $74,500 avg), followed by Senior Scientist I and Senior Research Associate. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Dicerna Pharmaceuticals, Inc is headquartered in Lexington, MA under NAICS code 325412, and places H-1B workers across 2 states, most heavily in MA, CO. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Dicerna Pharmaceuticals, Inc ranks. By H-1B petition volume, Dicerna Pharmaceuticals, Inc is #8,540 of 119,880 employers nationally and #361 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.